Advertisement
UK markets closed
  • NIKKEI 225

    38,405.66
    +470.90 (+1.24%)
     
  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     
  • CRUDE OIL

    81.76
    -0.87 (-1.05%)
     
  • GOLD FUTURES

    2,301.90
    -55.80 (-2.37%)
     
  • DOW

    37,962.14
    -423.95 (-1.10%)
     
  • Bitcoin GBP

    50,119.69
    -539.11 (-1.06%)
     
  • CMC Crypto 200

    1,284.62
    -54.45 (-4.07%)
     
  • NASDAQ Composite

    15,790.49
    -192.59 (-1.20%)
     
  • UK FTSE All Share

    4,430.25
    -4.93 (-0.11%)
     

RHÖN-KLINIKUM Full Year 2023 Earnings: EPS: €0.58 (vs €0.38 in FY 2022)

RHÖN-KLINIKUM (ETR:RHK) Full Year 2023 Results

Key Financial Results

  • Revenue: €1.74b (up 5.0% from FY 2022).

  • Net income: €38.7m (up 54% from FY 2022).

  • Profit margin: 2.2% (up from 1.5% in FY 2022). The increase in margin was driven by higher revenue.

  • EPS: €0.58 (up from €0.38 in FY 2022).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

RHÖN-KLINIKUM shares are down 1.8% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with RHÖN-KLINIKUM.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.